Items where authors include "Bermejo de Las Heras, B."

Article

Baird, R.D., Bermejo de Las Heras, B., Ruiz-Borrego, M. et al. (20 more authors) (2025) Camizestrant in combination with three globally approved CDK4/6 inhibitors in women with ER+, HER2- advanced breast cancer: Results from SERENA-1. Clinical Cancer Research, 31 (20). pp. 4244-4254. ISSN 1078-0432